Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus
- PMID: 21844496
- DOI: 10.1200/JCO.2011.36.2095
Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus
Comment in
-
How many therapeutic options are there for recurrent or metastatic salivary duct carcinoma?J Clin Oncol. 2012 Feb 20;30(6):672; author reply 672-673. doi: 10.1200/JCO.2011.39.4577. Epub 2012 Jan 17. J Clin Oncol. 2012. PMID: 22253461 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
